This inventor holds 1 USPTO granted patent. Top assignees: Chiba University, Fujikura Kasei Co., Ltd., The University of Osaka. Active years: 2026.
Company Filing History:
1 out of 155 
1 out of 1 
1 out of 3 Years Active: 2026
Title: Hiroyasu Iso: Innovator in Biomedical Detection
Introduction
Hiroyasu Iso is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of biomedical detection, particularly in the area of cerebral infarction risk assessment. His innovative work has the potential to enhance early detection methods, thereby improving patient outcomes.
Latest Patents
Hiroyasu Iso holds a patent for a groundbreaking invention titled "Body Fluid Antibody Biomarker for Highly Sensitive Detection of Risk of Onset of Cerebral Infarction." This patent represents a significant advancement in the detection of cerebral infarction, utilizing biomarkers found in body fluids to identify risks with high sensitivity. He has 1 patent to his name, showcasing his dedication to innovation in medical technology.
Career Highlights
Throughout his career, Hiroyasu Iso has worked with notable organizations, including Fujikura Kasei Co., Ltd. and Chiba University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research and development.
Collaborations
Hiroyasu Iso has collaborated with esteemed colleagues such as Go Tomiyoshi and Takaki Hiwasa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Hiroyasu Iso's contributions to biomedical detection exemplify the importance of innovation in healthcare. His patent for a highly sensitive biomarker detection method highlights his commitment to improving medical diagnostics. Through his work, he continues to pave the way for advancements that can significantly benefit patient care.